CY1113730T1 - A DIAVLENEOGENIC VETERINARY COMPOSITION THAT INCLUDES DETOMIDINE - Google Patents

A DIAVLENEOGENIC VETERINARY COMPOSITION THAT INCLUDES DETOMIDINE

Info

Publication number
CY1113730T1
CY1113730T1 CY20121100944T CY121100944T CY1113730T1 CY 1113730 T1 CY1113730 T1 CY 1113730T1 CY 20121100944 T CY20121100944 T CY 20121100944T CY 121100944 T CY121100944 T CY 121100944T CY 1113730 T1 CY1113730 T1 CY 1113730T1
Authority
CY
Cyprus
Prior art keywords
detomidine
diavleneogenic
veterinary composition
composition
semi
Prior art date
Application number
CY20121100944T
Other languages
Greek (el)
Inventor
Mirja Huhtinen
Piritta Koistinen
Lasse Leino
Maria Rantala
Helena Kaukinen
Ursin Kaija Af
Original Assignee
Orion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20041425A external-priority patent/FI20041425A0/en
Application filed by Orion Corporation filed Critical Orion Corporation
Publication of CY1113730T1 publication Critical patent/CY1113730T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση σχετίζεται με μια κτηνιατρική σύνθεση σε ημιστερεή μορφή η οποία είναι κατάλληλη για διαβλεννογονική χορήγηση ώστε να παρέχει καταστολή και αναλγησία σε μεγάλα ζώα όπως άλογα και βοοειδή. Η ημιστερεή διαβλεννογονική σύνθεση της εφεύρεσης περιλαμβάνει δετομιδίνη ή ένα φαρμακευτικά αποδεκτό άλας αυτής ως δραστικό συστατικό. Η σύνθεση προσφέρει γρήγορη έναρξη δράσης ενώ έχει χαμηλή ερεθιστικότητα στο στοματικό βλεννογόνο.The present invention relates to a semi-solid veterinary composition suitable for transgenic administration to provide suppression and analgesia to large animals such as horses and cattle. The semi-solid transmucosal composition of the invention comprises detomidine or a pharmaceutically acceptable salt thereof as an active ingredient. The composition offers a fast onset of action and has low irritation to the oral mucosa.

CY20121100944T 2004-11-05 2012-10-12 A DIAVLENEOGENIC VETERINARY COMPOSITION THAT INCLUDES DETOMIDINE CY1113730T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62512904A 2004-11-05 2004-11-05
FI20041425A FI20041425A0 (en) 2004-11-05 2004-11-05 Transmucosal veterinary composition
EP05804165A EP1811995B1 (en) 2004-11-05 2005-11-03 A transmucosal veterinary composition comprising detomidine

Publications (1)

Publication Number Publication Date
CY1113730T1 true CY1113730T1 (en) 2016-06-22

Family

ID=58448887

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100944T CY1113730T1 (en) 2004-11-05 2012-10-12 A DIAVLENEOGENIC VETERINARY COMPOSITION THAT INCLUDES DETOMIDINE

Country Status (1)

Country Link
CY (1) CY1113730T1 (en)

Similar Documents

Publication Publication Date Title
BRPI0517719A (en) transmucosal veterinary composition comprising detomidine
CY1117470T1 (en) SOLID DOSAGE PREPARATIONS WITH IMPROVED ANIMAL ADJUSTMENT
CY1115056T1 (en) Pharmaceutical Compositions Containing Fentanyl For Intranasal Administration
CY1114139T1 (en) BUPRENORPHINE PLATE FOR DRUG REPLACEMENT TREATMENT
CY1110954T1 (en) Semi-solid mucosal adhesives PHARMACEUTICAL FORMS
CY1116640T1 (en) PHARMACEUTICAL PREPARATION CONTAINING Oxycodone and Naloxone
EA200900211A1 (en) SUBSTITUTED IMIDAZOLONE DERIVATIVES, THEIR RECEIVING AND APPLICATION
CY1111446T1 (en) COMPOSITIONS OF CRYSTALL SUMMARY TRANS- (+/-) - DELTA-9-tetrahydrocannabinol
CY1112811T1 (en) BY ORAL DOSAGE FORMED INCLUDING RISK 4 AS AN ACTIVE INGREDIENT AND POLYBINYL PYROLIDONE AS EXCIPIENT
NO20043367L (en) Oral pharmaceutical preparation
CY1115289T1 (en) Methods of Treatment Against Inflammation-Related Illness
BR0201719A (en) Pharmaceutical compositions pleasant to the taste for pets
CY1106679T1 (en) AZADICYCLIC HETEROCYCLIC COMPOUNDS AS CANNABINOID RECEPTOR MODIFIERS
DE60140814D1 (en) N-PHENYL-2-PYRIMIDINE AMINE DERIVATIVE
CY1109242T1 (en) THERAPEUTIC AGENTS USEFUL FOR PAIN TREATMENT
CY1105202T1 (en) DISPERSED PHARMACEUTICAL COMPOSITIONS
CY1107384T1 (en) RAPIDLY DISPERSIBLE DOSAGE FORMS WITHOUT GELATIN
CY1105221T1 (en) MEDICINAL USE OF THYROIDOMIMETIC COMPOUNDS FOR THE THERAPEUTIC TREATMENT OF HAIR LOSS AND PHARMACEUTICAL COMPOSITIONS
BRPI0413079A (en) tasty ductile chewable veterinary composition
CY1111977T1 (en) PEPERIDIN-4-YL-PYRIDAZIN-3-YLAMINE DERIVATIVES AS HIGHLY DISTRIBUTED DOPAMIN COMPONENTS 2
CR7432A (en) ACTIVE REPLACED AMIDAS OF THE CANABINOID RECEIVER-1
CY1106240T1 (en) ISOTHIAZOLE-4-CARBOXAMIDE SALTS AND THEIR USE AS INHIBITORS OF CELL HYPERPROLIFERATION
CY1108430T1 (en) USE OF NETHERLANDS SIDE BASKET COMPETITORS WITH AMITERASE FOR ECOPARATOMETER CONTROLS IN HOUSEHOLD ANIMALS
CY1111698T1 (en) COMBINATION INCLUDING AN AT1 COMPETITIVE RECEPTOR AND AN INSULIN EXTRACTOR OR A INSULIN SENSITIVE
EA200500985A1 (en) SOLID MEDICAL FORM FOR ORAL APPLICATION